Cytochrome P-450 CYP2B6 Inhibitors

DBCAT001285Pharmacologic class

Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 CYP2B6. A DrugBank category of 85 drugs. 79 of them are approved.

Also known as
CYP2B6 Inhibitors · CYP2B6 Inhibitors, P450 · Cytochrome P 450 CYP2B6 Inhibitors · Cytochrome P-450 CYP2B6-Inhibitors · Cytochrome P450 2B6 Inhibitors

What you can answer from here — as of September 19, 2019

85DrugsEach linked to its full drug card
Sign in
348Drug targetsEvery drug–target pair in the class, with bond type
Sign in
48,432Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
37Routes of administrationHow the drugs in this class are given
Sign in
4SubcategoriesNarrower classes within this one
Sign in

Which targets do Cytochrome P-450 CYP2B6 Inhibitors share, and which companies have late-stage candidates in this class?

Create a free account or log in to explore the full data card.

Create Account